Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119611) titled 'Non-invasive individualized precision neuromodulation therapy for articulation disorders and exploration of the underlying neural plasticity mechanisms' on Feb. 28.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Bo'ai Hospital
Condition:
Dysarthria after stroke
Intervention:
Infrastructural group:Neuromodulation therapy
Control group:no-treatment control
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: Infrastructural group:25;Control group:26;Supratentorial group:26;
Countries of Recruitment:
China
To know more,...